GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Renascience Inc (TSE:4889) » Definitions » LT-Debt-to-Total-Asset

Renascience (TSE:4889) LT-Debt-to-Total-Asset : 0.19 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Renascience LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Renascience's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.19.

Renascience's long-term debt to total assets ratio increased from Jun. 2023 (0.16) to Sep. 2024 (0.19). It may suggest that Renascience is progressively becoming more dependent on debt to grow their business.


Renascience LT-Debt-to-Total-Asset Historical Data

The historical data trend for Renascience's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renascience LT-Debt-to-Total-Asset Chart

Renascience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
0.38 0.45 0.08 0.14 0.17

Renascience Quarterly Data
Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.16 0.17 0.17 0.19

Renascience LT-Debt-to-Total-Asset Calculation

Renascience's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=356.1/2088.833
=0.17

Renascience's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )/Total Assets (Q: Sep. 2024 )
=365.577/1957.093
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Renascience  (TSE:4889) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Renascience LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Renascience's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Renascience Business Description

Traded in Other Exchanges
N/A
Address
2-3-6 Nihombashi-Honcho, Chuo-ku, Tokyo, JPN, 103-0023
Renascience Inc is engaged in the research and development of new medical solutions by utilizing various modalities such as pharmaceuticals, medical devices, artificial intelligence and others to solve problems in the medical setting.

Renascience Headlines

No Headlines